Zucara Overview
- Founded
-
2014

- Status
-
Private
- Employees
-
12

- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$21M
- Investors
-
8
Zucara General Information
Description
Developer of a novel drug therapy designed to prevent hypoglycemia in people with diabetes. The company's drug therapy is delivered as a once-daily subcutaneous injection, which will benefit patients by addressing the significant morbidity and mortality associated with hypoglycemia, enabling healthcare providers to change diabetes disease management and improve both patient health and quality of life.
Contact Information
Website
www.zucara.ca
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 1300-661 University Avenue
- Toronto, Ontario M5G 0B7
- Canada
Zucara Timeline
Zucara Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC (Series A) | 31-Mar-2020 | $21M | 000.00 | Completed | Clinical Trials - Phase 1 | |
7. Grant | 12-Jul-2019 | 0000 | 00.000 | Completed | Pre-Clinical Trials | |
6. Debt - General | 09-Apr-2018 | 00.00 | 00.000 | Completed | Pre-Clinical Trials | |
5. Accelerator/Incubator | 09-Feb-2018 | 00000 | Completed | Pre-Clinical Trials | ||
4. Grant | 08-Feb-2018 | 00000 | 00000 | Completed | Pre-Clinical Trials | |
3. Grant | 21-Sep-2017 | 00000 | Completed | Pre-Clinical Trials | ||
2. Early Stage VC (Series A) | 03-Nov-2016 | Cancelled | Startup | |||
1. Early Stage VC | 03-Nov-2016 | $525K | $525K | Completed | Startup |
Zucara Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of a novel drug therapy designed to prevent hypoglycemia in people with diabetes. The company's drug therapy i
Drug Discovery
Toronto, Canada
12
As of 2022
000.00
00000000000
000.00
Zucara Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
0000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000&0 | 00000 |
Zucara Executive Team (6)
Zucara Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Christopher Garabedian | Self | Board Member | 000 0000 |
Claude Piché | Self | Board Member | 000 0000 |
Frederick Callori JD | Self | Board Member | 000 0000 |
Michael Martin | Zucara | Board Member | 000 0000 |
Michael Midmer | Zucara | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Zucara Signals
Zucara Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Perceptive Advisors | Hedge Fund | Minority | 000 0000 | 000000 0 | |
Xontogeny | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
GlycoNet | Not-For-Profit Venture Capital | 000 0000 | 000000 0 | ||
Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
National Research Council Canada | Government | 000 0000 | 000000 0 |